MedTrace Logo

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

NCT02971384 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 203

Last updated 2021-05-04

No results posted yet for this study

Summary

Aim of this study is to investigate efficacy and safety of Echinaforce Junior Tablets (250mg) in comparison with Vitamin C tablets in the prevention of acute viral respiratory tract infections.

Conditions

  • Respiratory Tract Infection Viral

Interventions

DRUG

Echinaforce

Sponsors & Collaborators

  • A. Vogel AG

    lead INDUSTRY

Principal Investigators

  • Mercedes Ogal, Dr. med. · Arztpraxis für Kinder und Jugendliche

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-25
Primary Completion
2017-08-03
Completion
2018-07-03

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971384 on ClinicalTrials.gov